diosurgery achieves a good functional outcome; facial function is preserved for 95%-100% of patients 7, 35 and useful hearing for 61%-78%. 4, 31, 45 Under certain circumstances, a surgeon might be requested to perform curative tumor removal of a small AN, usually to preserve facial function and hearing. To achieve excellent functional outcome after surgery, we have refined the microsurgical technique and intraoperative auditory monitoring for retrosigmoid removal of small ANs. Our newly designed intracranial electrode enables continuous and reliable auditory monitoring by use of cochlear nerve compound action potentials (CNAPs). 49, 51, 54 We report long-term outcomes of curative tumor removal with preservation of hearing and facial function; thus, we recommend that tumor removal be the first-line management strategy for younger patients with small ANs and preserved hearing.
Methods
During the period of 1998-2012, we consecutively enrolled 44 patients (19 men and 25 women, 22-69 years of age [mean age 52 ± 12 years]) with small ANs and preserved hearing who underwent curative tumor removal in an attempt to preserve facial and hearing functions. To meet the study inclusion criteria, patients needed to have a small AN, have serviceable hearing preoperatively, and be younger than 70 years of age. A small AN was defined as a purely intracanalicular AN without cerebellopontine angle extension (6 patients) or an AN with a cerebellopontine angle extension in which the maximal diameter of the cerebellopontine angle tumor was 15 mm or less (38 patients) . During the study period, we performed tumor removal in 240 patients with previously untreated ANs; therefore, these 44 study patients accounted for 18% of our total AN experience. According to the guidelines of the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery Foundation, 11 serviceable hearing is defined as Class A, B, or C. The preoperative hearing levels of the 44 study patients were Class A, 19 patients; Class B, 17; and Class C, 8 (Table 1) . Furthermore, those with a hearing level of Class A or B were designated as the useful hearing group; they had pure tone averages of 50 dB or less and speech discrimination scores of 50% or more.
Curative Tumor Removal With Preservation of Function via the Retrosigmoid Approach
All patients underwent retrosigmoid tumor removal. The goals were curative (total) tumor removal and preservation of hearing and facial function.
Surgical Technique for Functional Preservation
Because the retrosigmoid AN removal surgical technique has been reported elsewhere, 53 ,54 herein we list several points with regard to curative total tumor removal and preservation of function, especially hearing.
Minimal Cerebellopontine Angle Arachnoid Dissections. In patients with a small AN, especially those with a pure intracanalicular tumor, the cerebellopontine angle arachnoid dissection was limited to the minimal area near the porus acusticus. The restricted arachnoid dissection prevented the cerebellum from sinking downward from gravity, which has been shown to be the typical cause of hearing loss because of longitudinal traction of the acoustic nerve. 10 Petrous Dura Flap to Protect the Cerebellopontine Angle. Before the posterior wall of the internal auditory canal was drilled, the dura of the petrous bone that forms the posterior wall was peeled off as a flap from the fundus side to the porus side. The petrous dura flap, secured by using a brain retractor, protected the cerebellopontine angle during posterior wall drilling (Fig. 1A) .
Posterior Wall Drilling. The petrous bone was drilled wide enough on both sides of the internal auditory canal to provide a sufficient extraction area; however, to preserve the common crus, we limited drilling on the lateral (fundus) end. We began drilling with a large (3-mm) steel bur head and then used a 3-mm diamond bur head to skeletonize the internal auditory canal dura. The last stage of internal auditory canal skeletonization comprised trimming the sides and fundus area of the internal auditory canal by using a smaller (2-mm) diamond bur head (Fig.  1B) . Sufficient drilling caused the meatal tumor to bulge out by itself; however, at this time, the tumor was still covered by the dura (Fig. 1C) .
Harvesting of the Petrous Dura Flap for Internal Auditory Canal Reconstruction.
After completing adequate posterior wall drilling, we removed the petrous dura flap and preserved it for subsequent internal auditory canal reconstruction.
Wide Removal of the Internal Auditory Canal Dura.
To gain wide exposure of the intrameatal nerves and tumor, after cutting the sides and lateral end, we removed the exposed internal auditory canal dura in its entirety as a single sheet.
Sharp Tumor Dissection.
We then dissected the tumor from the nerves (vestibular, cochlear, and facial) by using microscissors and microknives in the same way that they would be used for dissecting the arachnoid membrane and trabeculae.
Tumor Debulking. The tumor and the surrounding nerves were tightly packed in the internal auditory canal. Dissection of the tumor without first debulking it would have caused unexpected compression or damage to the preserved nerve. Therefore, intracapsular tumor debulking is always mandatory, even in patients with small ANs. Tumor debulking using ring or blunt dissectors can compress and damage the nerves surrounding the tumor. Thus, we debulked the tumor by using microscissors and microknives. Last, the tumor was removed piece by piece by using microscissors throughout the dissection.
Tumor Removal Near the Fundus of the Internal Auditory Canal. Tumor excision near the fundus was the last and most hazardous stage of tumor removal. With direct visualization of the fundus area, we cautiously and sharply dissected the tumor out by using microscissors.
Preservation of Nerve Function. For hemostasis, we used oxidized cellulose, surgical patties, saline irrigation, and, sometimes, an application of gentle pressure, which was sufficient.
Internal Auditory Canal Reconstruction and Restoring the CSF Space in the Internal Auditory Canal.
As mentioned, the petrous dura flap was harvested for internal auditory canal reconstruction (Fig. 1D) . 50 After completion of the tumor removal, the roof of the internal auditory canal was reconstructed by using the harvested dura flap. Thereafter, muscle or fat grafts were placed on this roof to fill up the removed posterior wall. The new internal auditory canal roof separated the preserved cochlear and facial nerves from the grafts and restored the space in the internal auditory canal (Fig. 2) .
Intraoperative Monitoring of Auditory and Facial Function
During surgery, we performed simultaneous and continuous monitoring of the auditory brainstem responses (ABRs) and CNAPs. 51, 54 In brief, ABRs were monitored throughout the duration of the surgery, and CNAPs were monitored continuously throughout intradural microsurgery by using our newly developed intracranial elec- trodes. Facial function was monitored by intermittent electrical stimulation of the intracranial facial nerve with the NIM nerve monitoring system (Medtronic).
Postoperative Follow-Up
After tumor removal, all patients were regularly examined at the outpatient clinic every 3-6 months. To confirm the extent of tumor removal, they underwent the first postoperative Gd-enhanced MRI 12 months after surgery; to evaluate tumor recurrence, they underwent follow-up Gd-enhanced MRI every year thereafter. Data analysis was performed by using StatView software (SAS Institute Inc.), and statistical significance was defined as p ≤ 0.05. Data are expressed as means and standard deviations.
This study adhered to the World Medical Association Declaration of Helsinki and the guidelines for clinical research published by the ethical committee of Chiba Central Medical Center. All patients gave informed consent before inclusion in this study.
Results

Outcomes of Tumor Removal and Preservation of Function
Total tumor removal was achieved for all patients and confirmed by surgical records and the first postoperative Gd-enhanced MRI (12 months after surgery). Postoperative hearing levels were Class A, B, C, and D for 5, 21, 11, and 7 patients, respectively (Table 1) . Postoperative rates of preservation of serviceable and useful hearing were 37/44 (84%) and 26/36 (72%), respectively. The postoperative rate for preservation of serviceable hearing was 95% among patients with preoperative Class A hearing, 88% among those with Class B hearing, and 50% among those with Class C hearing (p = 0.01). Serviceable hearing was preserved for 92% of patients with preoperative Class A or B hearing and 50% of patients with preoperative Class C hearing (p < 0.01). A mild facial palsy (HouseBrackmann Grade II) occurred in 2 patients (5%) during the first postoperative week, but normal facial function had been recovered (House-Brackmann Grade I) when they were seen in the outpatient clinic. No deaths or other postoperative complications occurred. (Fig. 3) Monitoring of ABRs during tumor removal was often disrupted by artifacts from various surgical equipment and procedures. Among the 44 patients, reliable monitoring of ABRs with the distinct wave V was consistently obtained in 14 (32%), was intermittently obtained in 10 (23%), and was either unreliable or not obtained in 20 (45%) ( Table 2 ). Consistently reliable ABR monitoring was obtained in 11 (58%) of 19 patients with preoperative Class A hearing, 3 (18%) of 17 with preoperative Class B hearing, and 0 of 8 with preoperative Class C hearing (p < 0.01). Useful hearing was preserved postoperatively in 12 (86%) of 14 patients with consistently reliable ABRs, but in only 9 (45%) of 20 patients with unreliable/not obtained ABRs (p < 0.05).
Intraoperative Auditory Monitoring
Cochlear nerve compound action potentials were not affected by artifacts of surgical equipment and procedures. Reliable CNAPs were obtained consistently throughout microsurgical tumor removal in 29 (66%) of the 44 patients, and reliable auditory monitoring was achieved more frequently with CNAPs than with ABRs (66% vs 32%, p < 0.01). Cochlear nerve compound action potentials were intermittently reliable in 7 patients and unreliable/not obtained in 8 patients (Table 2) . Useful hearing was preserved postoperatively in 22 (76%) of 29 patients with consistently reliable CNAPs and in 4 (27%) 
Long-Term Postoperative Follow-Up Results of Gd-Enhanced MRI and Audiological Examinations
During the long-term Gd-enhanced MRI follow-up period (81 ±
Discussion
Wait-and-Scan for Patients With Small ANs and Preserved Hearing
Observation management with imaging follow-up (wait-and-scan) has become the prevalent strategy for managing small ANs. This approach has revealed that the natural history of ANs as a whole is benign and that the mean tumor growth rate is 1.0-3.0 mm per year.
2,44,52
However, the wait-and-scan strategy has also revealed that the growth rate and pattern of small ANs vary widely among patients. Growth rates are less than 1 mm per year for more than 60% of patients and more than 3 mm per year for 12% of patients. 2 Moreover, no significant association has been found between tumor growth rate and factors such as sex, age, initial hearing status, or preliminary tumor grade. 2, 52 Because the tumor growth of each patient is unpredictable, the ideal interval for imaging follow-up studies is not fixed.
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Previous reports of the wait-and-scan approach for patients with small ANs and preserved hearing have indicated that hearing progressively declines regardless of tumor growth. Specifically, 1 study showed that pure tone averages among 47 patients with intracanalicular AN deteriorated from 38 dB to 51 dB and that 26% of useful hearing was lost during the 3.6-year duration of the waitand-scan management strategy. 33 Another study revealed that over a follow-up period of more than a decade, most patients with preserved useful hearing lost the useful hearing regardless of tumor growth. 43 These studies provide compelling evidence that, to avoid the progressive hearing decline that has been reported for the prevalent wait-and-scan approach, tumor removal should be the first treatment option for younger patients with small ANs and preserved hearing.
Long-Term Outcome of Curative Small AN Removal With Preservation of Function
In our study, retrosigmoid removal of small ANs in 44 patients with preserved hearing was accomplished with excellent functional outcomes. Curative tumor removal was confirmed by long-term MRI follow-up examinations.
One of the main and most challenging focuses in the management of small ANs is preservation of hearing. In our study, the rates of postoperative preservation of useful and serviceable hearing were 72% and 84%, respectively. Table 3 summarizes the outcome of hearing and facial function after tumor removal and radiosurgery of small ANs. Two surgical approaches (the retrosigmoid approach and the middle fossa approach) are currently used for small AN removal in cases where hearing preservation is desired. Although it has previously been claimed that a higher rate of hearing preservation can be accomplished with the middle fossa approach than with the retrosigmoid approach, 22 recent publications have suggested that there is no difference between the 2 approaches (that is, hearing is preserved for 50%-77% of patients after the retrosigmoid approach 9, 25, 29, 36 and for 52%-73% after the middle fossa approach 9, 13, 21, 39 ). By using the retrosigmoid approach, we achieved the same level of preservation (72%) in the study reported here.
We showed that better preoperative hearing resulted in a higher rate of postoperative hearing preservation: 95% preservation for patients with preoperative Class A hearing, 88% for Class B, and 50% for Class C. Therefore, hearing preservation after tumor removal is associated with the preoperative hearing level. 4 Intraoperative auditory monitoring during this study showed that reliable auditory monitoring was more frequently obtained for patients with better preoperative hearing. Moreover, reliable monitoring was also associated with higher rates of postoperative hearing preservation. In this study, intraoperative auditory monitoring with ABRs and CNAPs was performed simultaneously and reliable auditory monitoring more frequently with CNAPs than with ABRs (66% vs 32%, p < 0.01). Because of their large amplitude, CNAPs can almost be monitored in real time, thus giving the surgeon intraoperative feedback. 8, 51 This feedback enables the surgeon to refine the surgical technique in an attempt to preserve hearing and facial function intraoperatively, thereby improving functional outcome. Several points with regard to surgical technique for preservation of hearing and facial function are detailed above. However, the most critical point for preservation of hearing and facial function is sharp dissection with microscissors and microknives. Blunt dissection not only damages nerves by indirect compression but also damages small vessels that have mild adhesions.
Although removal of medium or large ANs carries a considerable risk for facial palsy, 38 a series of recent studies of removal of small ANs reported high rates of facial function preservation (88%-100%) 9, 13, 16, 18, 21, 23, 24, 27, 36, 37, 42 ( Table 3 ). In our study, the rate of normal facial function preservation (House-Brackmann Grade I) was 100%. In reports published during the 1980s-1990s, the rates of good facial function preservation after small AN removal were unsatisfactory (72%-94%). 3, 17, 22, 38 The increased success can be attributed to the development of surgical and monitoring techniques. With regard to surgical approaches, we and others have found that the retrosigmoid approach can offer better postoperative facial function than the middle fossa approach. 32, 36 This is so because for the access route of the middle fossa approach, the facial nerve is located in front of the tumor, but for the retrosigmoid approach, the nerve is located behind the tumor; thus, during tumor removal, the middle fossa approach requires greater manipulation of the facial nerve. 32 Preservation of facial function is also excellent (95%-100%) after radiosurgery.
7,30,35
Progressive Hearing Decline After AN Treatment
The highest rates of hearing preservation after treatment of small ANs are achieved with radiosurgery; useful hearing is preserved for 61%-78% of patients 15, 31, 45 However, preserved hearing after radiosurgery has been shown to progressively decline. This progressive decline is typical and definite; hearing preservation rates are 43%-57% at 5 years after radiosurgery and decrease to 34%-45% at 10 years. 7, 20, 34 In our study, after retrosigmoid tumor removal, the occurrence of postoperative decline of preserved hearing was rare and the level of the postoperative decline was minimal; that is, over the long term, useful hearing and serviceable hearing were preserved for 80% and 100% of patients, respectively. Yomo et al. reported that the rate of annual hearing decrease among AN patients was 5.39 dB per year and 3.77 dB per year before and after radiosurgery, respectively. 55 In our study, the rate of annual hearing decrease after retrosigmoid small AN removal was 1.2 dB per year, which is much lower than that after radiosurgery. In addition, it is possible that the postoperative hearing decline found in this study might represent natural hearing decline from aging (presbycusis). Postoperative declines in hearing after tumor removal through the middle fossa approach have been documented. 41 After tumor removal, scarring of the preserved cochlear nerve occurs as a consequence of fat or muscle graft packing of the internal auditory canal and results in delayed hearing declines. 6, 41 We reconstructed the internal auditory canal after tumor removal by using the petrous dura flap to restore the CSF space of the internal auditory canal. 50 Recovery of the CSF space prevents scarring of the preserved nerve, and this method of internal auditory canal reconstruction can contribute to long-term hearing preservation after tumor removal. Mazzoni et al. recently reported that after retrosigmoid AN removal, 87% of preserved useful hearing was maintained at the same level over a long-term follow-up period of 6-21 years. 26 Recent studies of the middle fossa approach tumor removal showed no or minimal hearing decline in the postoperative follow-up period. 16, 49 Learning Curve for Microsurgery and Radiosurgery Surgical removal of ANs requires a profound knowledge of anatomy and long-standing experience with sophisticated microsurgical technique. The expertise of the surgeon and/or surgical teams affects the outcome of this technically demanding procedure, and the existence of a learning curve has been reported. 14, 46 To attain surgical results similar to those reported by expert surgeons, experience with 20-50 cases is necessary. 5, 28, 47 Before starting the series of cases reported here, the senior author had removed more than 60 ANs, most of which were large/giant tumors. 53 Despite the relatively small number of patients in this series, we removed 240 previously untreated ANs during the same period. Our study shows excellent results regarding preservation of hearing and facial function as well as total tumor removal; therefore, no learning curve was observed. Radiosurgical treatment of ANs requires precise anatomical definition and optimal dose distribution. Because of continuous advances in imaging technology and the refinement of radiosurgical technology, radiosurgery requires improvement of skill and knowledge. A learning curve exists for radiosurgical dose planning of AN treatment, although the effect on the clinical outcome has not yet been elucidated. 56 
Management Paradigm for Small ANs
In this study, we analyzed the long-term outcome of 44 patients with preserved hearing who had undergone removal of small ANs; we showed that retrosigmoid tumor removal with auditory monitoring can accomplish curative tumor removal and excellent functional outcome without deaths or other postoperative complications. During waitand-scan of small ANs in patients with preserved hearing, progressive hearing decline occurs frequently, irrespective of tumor growth. After radiosurgery, progressive hearing decline is inevitable. Therefore, we propose that tumor removal, with preservation of hearing and facial function, should be the first-line management for small ANs in younger patients with preserved hearing. Figure 4 outlines this management algorithm. Briefly, patients younger than 70 years of age with preserved hearing and a small AN should be offered tumor removal with preservation of hearing and facial function. For patients 70 years of age or older, the wait-and-scan approach should be offered; thereafter, patients with tumor growth during the wait-and-scan period should be offered either tumor removal or radiosurgery.
Study Limitations and Strengths
This study has some limitations and several strengths. The limitations include the retrospective nature of the study, limited number of patients, potential biases of patient selection, and unknown natural history of AN. At the start of this study, we determined the inclusion criteria for patients who would undergo curative tumor removal with preservation of hearing and facial function (small AN, serviceable hearing, and age younger than 70 years). However, not all patients conforming to the inclusion criteria underwent this surgery because each patient selected his or her own treatment plan after being informed of the 3 treatment options (wait-and-scan, radiosurgery, or tumor removal). Not being a prospectively controlled trial, this study could not evade patient selection bias. Although the natural history of hearing and tumor growth of small ANs is discussed above in relation to the results of wait-and-scan study series, the real natural history of small ANs is unknown. The long-term outcomes after tumor removal and radiosurgery should be determined with regard to the real natural history of small ANs by using a well-controlled, randomized trial. However, the nature of ANs makes a well-controlled, randomized trial unpractical because attaining statistical significance would require sample sizes of more than 6700 patients in each study group. 48 Despite the limited number of patients in our study, the auditory monitoring using CNAPs and ABRs might have contributed to the excellent functional results achieved in this study. A major strength of this study is the long-term postoperative follow-up result obtained by Gd-enhanced MRI and audiological examinations.
Conclusions
Using the surgical technique, including sharp dissection and internal auditory canal reconstruction, in concert with intraoperative auditory monitoring of CNAPs and ABRs, we found that removal of small ANs via a retrosigmoid approach accomplished curative removal and excellent functional outcomes. No tumor recurred and the preserved hearing demonstrated no decline or minimal decline during the long-term follow-up period. Hearing decline during wait-and-scan and after radiosurgery is common and inevitable for patients with small ANs; therefore, we propose that curative tumor removal with preservation of hearing and facial function should be the 
